Back to search

Democritus University of Thrace (DUTH)

Μελέτη της παθογένειας των ιδιοπαθών διαμέσων πνευμονιών με μικροσυστοιχίες γενετικού υλικού (microarrays)

Abstract

dc:description

Idiopathic interstitial pneumonias (IIPs) are a heterogeneous group of diseases comprising of seven distinct clinical and pathological entities. Idiopathic pulmonary fibrosis (IPF) and cryptogenic organizing pneumonia (COP) represent two of the most prevalent members of the disease group with major differences in pathogenesis, clinical course and prognosis. The incidence of IPF is estimated at 6.8-16.3 cases per 100.000 per year in the United States, and the mean survival from the time of diagnosis is 3-5 yr regardless of treatment. IPF is a refractory and lethal IIP characterized by fibroblast proliferation, extracellular matrix deposition and progressive lung scarring, comprising the histopathologic pattern of usual interstitial pneumonia (UIP). In UIP, areas of accumulated fibroblasts and myofibroblasts mainly distributed in subepithelial areas of the intersititium, termed fibroblastic foci represent the pathogenetic hallmark of fibrogenesis. On the other hand, COP, is a patchy process involving alveolar ducts and alveoli, characterized by distinct fibromyxoid lesions called Masson bodies that are susceptible to even complete reversal, in contrast to fibroblastic foci that represent collections of highly proliferative fibroblastic-like cells resistant to apoptosis. These lesions may reflect differential wound repair responses to lung injury; the active fibrosis of IPF mirrors the abnormal wound repair in response to multiple sites of ongoing alveolar epithelial injury, involving increased activity and possibly exaggerated responses by a spectrum of proinflammatory and profibrogenic factors whereas that of COP may reflect normal wound repair response to pulmonary injury. In IPF, due to the lack of a more effective alternative, the fundamental therapeutic approach has been use of corticosteroids, alone or in combination with other immunosuppressive agents; however, this has little impact on long-term survival and is effective only in a minority of affected individuals. While the treatment of IPF remains elusive, COP presents with excellent prognosis and corticosteroid treatment responsiveness. Several studies have attributed these differences to distinct pathogenetic characteristics reflected by regional differences in apoptotic and angiogenic profiles. In an attempt to elucidate pathogenetic differences between these two disease entities and delineate potential mechanisms explaining distinct regional apoptotic and angiogenic profiles we investigated the expression of HIF-1a and telomerase in experimental models of pulmonary fibrosis and in patients with IPF and COP. A. HIF-1a in the pathogenesis of pulmonary fibrosis HIF-1a is recognized as a master regulator of hypoxic signaling by activating gene transcription of genes encoding proteins that mediate the cellular adaptive response under hypoxic conditions. Hypoxia, the lack of oxygen, can modulate alveolar epithelial cell homeostasis by promoting significant and adverse effects on epithelial function, including VEGF and surfactant protein production, disruption of cytoskeleton integrity, and the triggering of apoptosis through induction of p53 expression. Alveolar hypoxia can also promote macrophage recruitment and enhanced expression of inflammatory mediators. Thus, hypoxia could represent a potential fibrotic stimulus through induction of epithelial apoptosis, angiogenesis and modulation of the inflammatory response. With the use of DNA microarrays we performed extensive expression profiling of disease progression in an animal model of the disease, compared our data with all publicly available expression profiles both from human patients and animal models and identified HIF-1a as one of the most deregulated genes. The mRNA levels of HIF-1a, as well as of HIF-1a target gene vegfa, were found upregulated upon administration of bleomycin and the development of pulmonary inflammation and fibrosis. Immunohistochemistry for HIF-1a confirmed overexpression of HIF-1a localizing it mainly at the epithelium. Notably, HIF-1a (and HIF-1 target gene vegfa) overexpression was observed early in the pathologic cascade, before any deterioration of lung architecture and consequent gas exchange problems, indicating an early role for HIF-1 in the development of the modeled disease. Since the bleomycin animal model is not fully representative of IPF due to its self limiting nature and rapidity of its development, we then investigated HIF-1a immunolocalization in lung samples from patients with IPF/UIP and COP/OP, two histopathologic patterns of pulmonary fibrosis with different clinical course and prognosis. We used the pioneering technology of tissue microarrays, which allowed us the simultaneous analysis of up to 250 samples in a single experiment under highly standardized conditions. ...

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tzouvelekis, Argyrios
  • Τζουβελέκης, Αργύριος

Subjects

dc:subject × 24

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/21064

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tzouvelekis, Argyrios; Τζουβελέκης, Αργύριος. Μελέτη της παθογένειας των ιδιοπαθών διαμέσων πνευμονιών με μικροσυστοιχίες γενετικού υλικού (microarrays). Democritus University of Thrace (DUTH), 2008. http://hdl.handle.net/10442/hedi/21064